NeuroBo Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • NeuroBo Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.55 USD/shares, a 26.7% increase year-over-year.
  • NeuroBo Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -4.77 USD/shares, a 86.1% increase year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -2.46 USD/shares, a 94.3% increase from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -43.4 USD/shares, a 119% decline from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -19.8 USD/shares, a 983% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$41.00 +94.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$43 -$24 -119% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$20 -$18 -983% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$2 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.